TrialAllergy2022

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status.

Shigeharu Fujieda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.